Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
As with all peptide therapies, protocol should be developed with a qualified provider who can assess your individual health context and goals
overactivation of PARPs, such as during extensive genotoxic stress, can result in significant NAD + depletion and subsequent compromise of cellular energy homeostasis
Results typically appear between 36 months
As with the Tesamorelin pairing, no published clinical trial has evaluated AOD-9604 and BPC-157 administered together, and any discussion of combining them reflects individual compound research applied side by side, not a tested joint protocol
Getting onto it is not an approval
However, some individuals may experience: Injection site reactions such as mild redness, itching, or swelling Water retention or mild fluid buildup, particularly in the early weeks Joint discomfort or stiffness, which often resolves as the body adjusts Tingling or numbness in the hands or feet (less common) Elevated blood glucose levels in individuals predisposed to insulin resistance It is worth noting that tesamorelin should not be used by individuals with active cancer, those who are pregnant, or patients with hypersensitivity to its components
US$ 21.07
US$ 21.87
US$ 28.71
US$ 24.55
